During the past decade, Department of Neurology, Medical School Hannover conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 3 clinical trials were completed, i.e. on average, 37.5% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 3 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Department of Neurology, Medical School Hannover" #1 sponsor was "Hoffmann-La Roche" with 3 trials, followed by "University of Ulm" with 3 trials sponsored, "Cytokinetics" with 2 trials sponsored, "ZevraDenmark" with 2 trials sponsored and "Apellis Pharmaceuticals, Inc." with 2 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Department of Neurology, Medical School Hannover" #1 collaborator was "Elan Pharmaceuticals" with 1 trials as a collaborator, "European Commission" with 1 trials as a collaborator, "Hannover Medical School" with 1 trials as a collaborator, "Medical University Innsbruck" with 1 trials as a collaborator and "Medical University of Warsaw" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Department of Neurology, Medical School Hannover" are "Amyotrophic Lateral Sclerosis" (9 trials), "Amyotrophic Lateral Sclerosis (ALS)" (2 trials), "Motor Neuron Disease" (1 trials), "Multiple Sclerosis" (1 trials) and "Multiple Sclerosis, Relapsing-Remitting" (1 trials). Many other conditions were trialed in "Department of Neurology, Medical School Hannover" in a lesser frequency.

Most popular intervention types in "Department of Neurology, Medical School Hannover" are "Drug" (12 trials), "Dietary Supplement" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Arimoclomol" (2 trials), "Antihistamine" (1 trials), "Calogen" (1 trials) and "Methylprednisolone" (1 trials). Other intervention names were less common.

The vast majority of trials in "Department of Neurology, Medical School Hannover" are 14 trials for "All" genders.

Currently, there are NaN active trials in "Department of Neurology, Medical School Hannover". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Department of Neurology, Medical School Hannover, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Department of Neurology, Medical School Hannover, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".